Found 108 Enz. Inhib. hit(s) with all data for entry = 9864 TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: <100nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: 550nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: 550nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: 550nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: 550nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: 550nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: 550nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical
US Patent
Beijing Hanmi Pharmaceutical
US Patent
Affinity DataIC50: 550nMAssay Description:IRAK4 kinase (purchased from Life Technologies, Cat. No.: PR5612U) was diluted to 2 folds of the final concentration (the final concentration is 0.76...More data for this Ligand-Target Pair
